MK-2206 has use medication
MK-2206 is a drug candidate being investigated to help treat cancer. Its chemical formula is C25H21N5O. It acts as an allosteric AKT inhibitor.It is a highly selective inhibitor of pan-Akt, namely, of all three Akt isoforms Akt1, Akt2, and Akt3.It is intended to be used with other cancer therapies that advanced tumours may become resistant to.
utilizes employs makes use of is equipped with possesses